Lawrence E. Roebel

Pharmacological effects of MDL 11,939: A selective, centrally acting antagonist of 5‐HT2 receptors

H. Yamamura, N. Wiech, M. Palfreyman, 1988 .

Correlation between inotropic activity and drug plasma levels of a new cardiotonic agent, MDL 19205

D. Weiner, J. K. Woodward, Richard A. Okerholm, 1985 .